Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
about
Genome-wide association analysis of metabolic traits in a birth cohort from a founder populationScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trialInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives.Distinct variants at LIN28B influence growth in height from birth to adulthood.Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study.Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-AnalysisPubertal timing and growth influences cardiometabolic risk factors in adult males and females.Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women.The metabolic syndrome in polycystic ovary syndrome.Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsRisk of cardiovascular events in mothers of women with polycystic ovary syndrome.Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular diseaseInterleukin-6-174 G/C promoter polymorphism is associated with persistence of Chlamydia pneumoniae antibodies in young men.Chlamydia pneumoniae infection is associated with elevated body mass index in young men.Glucose intolerance states in women with the polycystic ovary syndrome.Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity.Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome.Risk factors for acute respiratory tract illness in military conscripts.The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966.Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levelsFull-length visfatin levels are associated with inflammation in women with polycystic ovary syndromeMetabolic and reproductive characteristics of first-degree relatives of women with self-reported oligo-amenorrhoea and hirsutismThe Association between Oligomenorrhea, Onset of Menopause and Metabolic Syndrome in Thai Postmenopausal Women
P2860
Q24654676-670D5BAA-F4BC-4B3F-9CED-1A1AE1B3A6C2Q28390200-9C8E4C85-2B72-48D4-B99C-74245E4FC55EQ28394688-793F670B-6755-401C-806F-0B46EC415583Q33569169-01591380-EC3F-4F46-B84C-1FB8DC8CF82FQ33736117-FB8E8417-0E65-4837-8B39-85E8D41389B3Q33847232-ADE4FFA4-316E-4AC6-BEB8-5AC73A23A966Q34181522-C906A1C1-064D-4655-A9B3-71ECF03D4D2DQ34698200-9C18CE56-4A3F-42D3-892A-188C6DF857A7Q34817037-D9D0976C-C983-4F5C-B949-A1A059E11A25Q35770685-EF6DCC19-24AF-4ABD-A9A1-F4A1844651D3Q35810003-82A09EF1-C23E-405A-9E24-1EF9D451DECBQ35841278-75310EEB-8B2F-4DAE-817F-E42FE13B7D0FQ36069838-531AFBF8-1AAF-4F1A-A748-A0F2BA6BEA78Q36472269-3EF51169-5EF5-4100-AA68-0CBDB44675B4Q36536790-7A2B9B49-9782-4F06-A36E-D8F7DC384831Q37091345-E7960D94-2202-49CC-A4C5-D27AD57ECC24Q37097161-C7E4FDE0-9FB4-4EB6-BC4C-A00B822A6D45Q37851321-191B8A9E-BD5F-4795-94AC-6AC816DAC851Q37853903-E17C492F-60B0-48F5-98BE-6A341C00FC38Q38150697-C53753F9-143C-4655-9388-28B685A1A8C4Q40184611-D84FC945-374E-45AF-B1B0-4D5975E84D45Q40716291-8C793E36-45E6-4FFF-89A7-748AEF099394Q44221511-37F8C3DE-7E46-49AC-B503-A45033E29BFBQ45742269-71DCD308-97B9-427D-BEE8-C3F4737321BCQ50056959-854130EE-8803-4AF3-84C8-506A01024EF7Q57116412-ED8ED2C7-D0C5-4C60-888B-FC58665D392FQ57118231-9C903040-E32A-4BBE-A8CD-829F0EE69310Q57118806-44DF0D8C-20D9-4785-8DED-4628CCA84C13Q58781170-0DA74F5F-1A07-4891-A0BD-6E6468D7DE3F
P2860
Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Metabolic cardiovascular disea ...... nland Birth Cohort 1966 Study.
@en
Metabolic cardiovascular disea ...... nland Birth Cohort 1966 Study.
@nl
type
label
Metabolic cardiovascular disea ...... nland Birth Cohort 1966 Study.
@en
Metabolic cardiovascular disea ...... nland Birth Cohort 1966 Study.
@nl
prefLabel
Metabolic cardiovascular disea ...... nland Birth Cohort 1966 Study.
@en
Metabolic cardiovascular disea ...... nland Birth Cohort 1966 Study.
@nl
P2093
P50
P921
P356
P1476
Metabolic cardiovascular disea ...... nland Birth Cohort 1966 Study.
@en
P2093
Aimo Ruokonen
Anna-Liisa Hartikainen
Anneli Pouta
Hannu Martikainen
Jaana Laitinen
Mika Paldanius
Northern Finland Birth Cohort 1966 Study
Saara Taponen
Stephen Franks
P304
P356
10.1210/JC.2003-031720
P407
P577
2004-05-01T00:00:00Z